Cite

    Nywening, T. M., Belt, B. A., Cullinan, D. R., Panni, R. Z., Han, B. J., Sanford, D. E., Jacobs, R. C., Ye, J., Patel, A. A., Gillanders, W. E., Fields, R. C., DeNardo, D. G., Hawkins, W. G., Goedegebuure, P., & Linehan, D. C. (2018). targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma. Gut, 67(6), 1112–1123. http://access.bl.uk/ark:/81055/vdc_100135134510.0x00003e